GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (FRA:GEKA) » Definitions » Change In Other Working Capital

Genomma Lab InternacionalB de CV (FRA:GEKA) Change In Other Working Capital : €-1.1 Mil (TTM As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Change In Other Working Capital?

Genomma Lab InternacionalB de CV's Change In Other Working Capital for the quarter that ended in Mar. 2025 was €4.7 Mil. It means Genomma Lab InternacionalB de CV's Other Working Capital increased by €4.7 Mil from Dec. 2024 to Mar. 2025 .

Genomma Lab InternacionalB de CV's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €12.7 Mil. It means Genomma Lab InternacionalB de CV's Other Working Capital increased by €12.7 Mil from Dec. 2023 to Dec. 2024 .


Genomma Lab InternacionalB de CV Change In Other Working Capital Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Change In Other Working Capital Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.31 -10.50 21.67 46.68 12.71

Genomma Lab InternacionalB de CV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.63 -27.85 14.00 8.12 4.67

Genomma Lab InternacionalB de CV Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomma Lab InternacionalB de CV Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines